Recent Company News

• 02:30 PM ET Feb 11, 2026
  

  StreetAccount Event preview: AAP v RFK Jr PI hearing on Friday the 13th

• 09:42 AM ET Feb 11, 2026
  

  FDA panel to meet 12-Mar to discuss flu vaccine strain composition for 26-27

• 02:03 AM ET Feb 10, 2026
  

  GSK PLC announces China CDE accepts Arexvy adults 60+ application (2159.0000p, 0)

• 03:47 PM ET Feb 09, 2026
  

  FDA discloses paragraph IV patent certifications, including Trelegy Ellipta (GSK), Leqvio (ALNY), and a new dose of Neffy (SPRY)

• 04:05 AM ET Feb 09, 2026
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (137 total)

• 09:26 PM ET Feb 06, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 02:56 PM ET Feb 06, 2026
  

  StreetAccount Sector Summary: Healthcare Monthly Recap - January 2026

• 10:06 AM ET Feb 06, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (384 total)

• 04:20 AM ET Feb 06, 2026
  

  GSK Plc downgraded to hold from buy at Landesbank Baden-Wuerttemberg (LBBW) (2159.0000p, -21)

• 02:04 AM ET Feb 06, 2026
  

  European Commission has approved GSK's Nucala (mepolizumab), a monoclonal antibody targeting interleukin-5 (IL-5), in adults as an add-on maintenance treatment for uncontrolled COPD (2180.0000p, 0)